Literature DB >> 24586049

NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation.

Ann-Kathrin Eisfeld1, Sebastian Schwind, Kevin W Hoag, Christopher J Walker, Sandya Liyanarachchi, Ravi Patel, Xiaomeng Huang, Joseph Markowitz, Wenrui Duan, Gregory A Otterson, William E Carson, Guido Marcucci, Clara D Bloomfield, Albert de la Chapelle.   

Abstract

Neuroblastoma rat sarcoma (RAS) viral oncogene homolog (NRAS), a small GTPase, is one of the most thoroughly studied oncogenes that controls cell growth, differentiation, and survival by facilitating signal transduction. Here, we identify four novel naturally occurring NRAS isoforms (isoforms 2-5) in addition to the canonical isoform (isoform 1). Expression analyses performed on a panel of several different human malignancies and matching normal tissue revealed distinct isoform expression patterns. Two of the novel isoforms were found in the nucleus and cytoplasm, whereas the others were exclusively cytoplasmic. The isoforms varied in their binding affinities to known downstream targets and differentially regulated the RAS signaling pathway. Strikingly, forced expression of isoform 5, which encodes only a 20-aa peptide, led to increased cell proliferation and to transformation by activation of known NRAS targets. These discoveries open new avenues in the study of NRAS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24586049      PMCID: PMC3964043          DOI: 10.1073/pnas.1401727111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Ras oncogenes and their downstream targets.

Authors:  Krishnaraj Rajalingam; Ralf Schreck; Ulf R Rapp; Stefan Albert
Journal:  Biochim Biophys Acta       Date:  2007-01-28

2.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

3.  High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.

Authors:  S Bezieau; M C Devilder; H Avet-Loiseau; M P Mellerin; D Puthier; E Pennarun; M J Rapp; J L Harousseau; J P Moisan; R Bataille
Journal:  Hum Mutat       Date:  2001-09       Impact factor: 4.878

Review 4.  Targeting oncogenic Ras signaling in hematologic malignancies.

Authors:  Ashley F Ward; Benjamin S Braun; Kevin M Shannon
Journal:  Blood       Date:  2012-08-16       Impact factor: 22.113

5.  Association of p21ras with phosphatidylinositol 3-kinase.

Authors:  A Sjölander; K Yamamoto; B E Huber; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

Review 6.  The guanine nucleotide-binding switch in three dimensions.

Authors:  I R Vetter; A Wittinghofer
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

Review 7.  Ras family signaling: therapeutic targeting.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Cancer Biol Ther       Date:  2002 Nov-Dec       Impact factor: 4.742

8.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

9.  A transforming gene present in human sarcoma cell lines.

Authors:  C J Marshall; A Hall; R A Weiss
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

10.  Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation.

Authors:  M Davis; S Malcolm; A Hall; C J Marshall
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  12 in total

1.  Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.

Authors:  Megan C Duggan; Kelly Regan-Fendt; Gonzalo N Olaverria Salavaggione; John Harrison Howard; Andrew R Stiff; Julia Sabella; Nicholas Latchana; Joseph Markowitz; Alejandro Gru; Susheela Tridandapani; Ann-Kathrin Eisfeld; Albert de la Chapelle; William E Carson
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

2.  Structural characterization of NRAS isoform 5.

Authors:  Joseph Markowitz; Tapas K Mal; Chunhua Yuan; Nicholas B Courtney; Mitra Patel; Andrew R Stiff; James Blachly; Christopher Walker; Ann-Kathrin Eisfeld; Albert de la Chapelle; William E Carson
Journal:  Protein Sci       Date:  2016-03-24       Impact factor: 6.725

3.  Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.

Authors:  Megan C Duggan; Andrew R Stiff; Maryam Bainazar; Kelly Regan; Gonzalo N Olaverria Salavaggione; Sophia Maharry; James S Blachly; Madison Krischak; Christopher J Walker; Nicholas Latchana; Susheela Tridandapani; Albert de la Chapelle; Ann-Kathrin Eisfeld; William E Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

4.  Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.

Authors:  Cara Lunn Shirai; James N Ley; Brian S White; Sanghyun Kim; Justin Tibbitts; Jin Shao; Matthew Ndonwi; Brian Wadugu; Eric J Duncavage; Theresa Okeyo-Owuor; Tuoen Liu; Malachi Griffith; Sean McGrath; Vincent Magrini; Robert S Fulton; Catrina Fronick; Michelle O'Laughlin; Timothy A Graubert; Matthew J Walter
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

Review 5.  The structural basis for cancer treatment decisions.

Authors:  Ruth Nussinov; Hyunbum Jang; Chung-Jung Tsai
Journal:  Oncotarget       Date:  2014-09-15

6.  Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.

Authors:  Vishesh Khanna; Scott T Pierce; Kim-Hien T Dao; Cristina E Tognon; David E Hunt; Brian Junio; Jeffrey W Tyner; Brian J Druker
Journal:  Cureus       Date:  2015-12-17

7.  AIDE: annotation-assisted isoform discovery with high precision.

Authors:  Wei Vivian Li; Shan Li; Xin Tong; Ling Deng; Hubing Shi; Jingyi Jessica Li
Journal:  Genome Res       Date:  2019-11-06       Impact factor: 9.043

8.  Murine Long Noncoding RNA Morrbid Contributes in the Regulation of NRAS Splicing in Hepatocytes In Vitro.

Authors:  Anna Fefilova; Pavel Melnikov; Tatiana Prikazchikova; Tatiana Abakumova; Ilya Kurochkin; Pavel V Mazin; Rustam Ziganshin; Olga Sergeeva; Timofei S Zatsepin
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

Review 9.  Splice variants of RAS-translational significance.

Authors:  Erzsébet Rásó
Journal:  Cancer Metastasis Rev       Date:  2020-08-08       Impact factor: 9.264

10.  EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.

Authors:  Yutian Wei; Chenfei Lu; Peng Zhou; Lin Zhao; Xiao Lyu; Jianxing Yin; ZhuMei Shi; Yongping You
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.